Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient-controlled sedation with midazolam, remimazolam, and dexmedetomidine in dental treatment
KCT0008615Phase 4Not yet recruiting
- Sponsor
- Seoul National University Dental Hospital
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of midazolam, remimazolam, dexmedetomidine in None, sponsored by Seoul National University Dental Hospital. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
midazolamremimazolamdexmedetomidine
Beyond the preview
Go deeper on KCT0008615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008615.